XHKG1717
Market cap435mUSD
Dec 27, Last price
1.90HKD
1D
-4.52%
1Q
-11.21%
Jan 2017
-38.51%
IPO
-61.38%
Name
Ausnutria Dairy Corp Ltd
Chart & Performance
Profile
Ausnutria Dairy Corporation Ltd, an investment holding company, primarily engages in the research and development, milk collection, processing, production, packaging, marketing, and distribution of infant formula and other dairy products. The company operates in two segments, Dairy and Related Products, and Nutrition Products. It offers cow milk-based formula products under the Allnutria, Hyproca Hollary, Hyproca Hypure, Neolac, and Puredo brand names; and goat milk-based infant formula products under the Kabrita brand. The company also produces formula milk powder products on an original equipment manufacturing basis. In addition, it engages in the manufacturing and distribution of nutrition products; development, distribution, and sale of probiotic products; and provision of financing services. The company operates in the People's Republic of China, the European Union, Southeast Asia, Australia, New Zealand, the Middle East, North and South America, and internationally. The company was founded in 2003 and is based in Sheung Wan, Hong Kong. Ausnutria Dairy Corporation Ltd operates as a subsidiary of HongKong Jingang Trade Holding Company Limited.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 7,382,007 -5.30% | 7,795,512 -12.15% | 8,873,274 11.11% | |||||||
Cost of revenue | 7,104,869 | 7,371,190 | 7,718,092 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 277,138 | 424,322 | 1,155,182 | |||||||
NOPBT Margin | 3.75% | 5.44% | 13.02% | |||||||
Operating Taxes | 32,945 | 62,934 | 231,426 | |||||||
Tax Rate | 11.89% | 14.83% | 20.03% | |||||||
NOPAT | 244,193 | 361,388 | 923,756 | |||||||
Net income | 174,387 -19.46% | 216,526 -79.19% | 1,040,262 3.60% | |||||||
Dividends | (98,460) | (430,176) | (388,161) | |||||||
Dividend yield | 2.10% | 5.73% | 2.38% | |||||||
Proceeds from repurchase of equity | 702,627 | 974,568 | ||||||||
BB yield | -9.36% | -5.99% | ||||||||
Debt | ||||||||||
Debt current | 2,394,575 | 1,092,047 | 739,942 | |||||||
Long-term debt | 58,673 | 563,211 | 688,530 | |||||||
Deferred revenue | 82,064 | 62,610 | ||||||||
Other long-term liabilities | 173,278 | 4,985 | 5,782 | |||||||
Net debt | 22,125 | (598,979) | (1,414,709) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 224,711 | (357,537) | 1,071,319 | |||||||
CAPEX | (609,974) | (704,543) | (556,391) | |||||||
Cash from investing activities | (740,917) | (723,984) | (606,566) | |||||||
Cash from financing activities | 682,453 | 664,108 | (34,087) | |||||||
FCF | (728,893) | (517,791) | 895,342 | |||||||
Balance | ||||||||||
Cash | 2,043,314 | 1,868,668 | 2,262,188 | |||||||
Long term investments | 387,809 | 385,569 | 580,993 | |||||||
Excess cash | 2,062,023 | 1,864,461 | 2,399,517 | |||||||
Stockholders' equity | 4,749,724 | 4,439,837 | 4,252,355 | |||||||
Invested Capital | 6,276,051 | 5,213,291 | 4,131,742 | |||||||
ROIC | 4.25% | 7.73% | 22.56% | |||||||
ROCE | 3.32% | 5.93% | 17.49% | |||||||
EV | ||||||||||
Common stock shares outstanding | 1,797,098 | 1,792,268 | 1,722,991 | |||||||
Price | 2.61 -37.71% | 4.19 -55.66% | 9.45 -26.74% | |||||||
Market cap | 4,690,426 -37.54% | 7,509,603 -53.88% | 16,282,267 -23.86% | |||||||
EV | 4,768,279 | 8,793,812 | 16,965,858 | |||||||
EBITDA | 527,807 | 680,796 | 1,432,233 | |||||||
EV/EBITDA | 9.03 | 12.92 | 11.85 | |||||||
Interest | 50,919 | 21,754 | 18,854 | |||||||
Interest/NOPBT | 18.37% | 5.13% | 1.63% |